Stifel Initiates Coverage On Alamar Biosciences with Buy Rating, Announces Price Target of $28

Stifel analyst Daniel Arias initiates coverage on Alamar Biosciences (NASDAQ:ALMR) with a Buy rating and announces Price Target of $28.